2022
181. Luca Noti, José A. Galván, Heather Dawson, Alessandro Lugli, Richard Kirsch, Naziheh Assarzadegan, David Messenger, Philippe Krebs, Martin D. Berger & Inti Zlobec (2022) –
A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer
180. Frederick George Mayall, Hanne-Brit Smethurst, Leonid Semkin, Trupti Mandalia, Muhammed Sohail, Rob Hadden, Leigh Biddlestone (2022). A Feasibility Study of Multisite Networked Digital Pathology Reporting in England
179. Temprana-Salvador, J., López-García, P., and Vives, J.C. (2022). DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals—Planification, Implementation, and Preliminary Results
2021
178. Paulik, R., Kozlovszky, M., Molnár, B. (2021) Regression Based Iterative Illumination Compensation Method for Multi-Focal Whole Slide Imaging System Sensors
177. Rubisz, P., Hirnle, L., and Kobierzycki, C. (2021) The Immunohistochemical Expression of MCM-3, -5, and -7 Proteins in the Uterine Fibroids Curr. Issues Mol. Biol.
176. Meriläinen, A-S., Sihto, H., and Koljonen, V. (2021) Merkel cell polyomavirus is a passenger virus in both poroma and porocarcinoma J Cutan Pathol.
175. Spiridonov, N., Asaulenko, Z. P., and Krivolapov, Yu. A. (2021) Analysis of the phenotypic heterogeneity of CD123-positive cells in Kikuchi-Fujimoto disease using a sequential immunoperoxidase labeling and erasing method Arkhiv Patologii
174. Kaprio, H., Heuser, V. D., Orte, K., Tukiainen, M., Leivo, I., and Gardberg, M. (2021) Expression of Transcription Factor CREM in Human Tissues Journal of Histochemistry & Cytochemistry
173. Chea, V., Pleiner, V., Schweizer, V., Herzog, B., Bode, B., and Tinguely, M. (2021) Optimized workflow for digitalized FISH analysis in pathology Diagnostic Pathology
172. Strohmeier, S., Brcic, I., Popper, H., Liegl-Atzwanger, B., Lindenmann, J., and Brcic, L. (2021) Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma Scientific Reports
171. Frankenstein, Z., Uraoka, N., Aypar, U., Aryeequaye, R., Rao, M, Hameed, M., Zhang, Y, and Yagi, Y. (2021) Automated 3D scoring of fluorescence in situ hybridization (FISH) using a confocal whole slide imaging scanner Applied Microscopy
170. Viborg Lindskrog, S., Prip, F., […] and Dyrskjot, L. (2021) An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer Nature Communications
169. Lee, C-J., Wozniak, A., Van Cann, T., Timmermans, I., Wellens, J., Vanleeuw, U., Briaire-de Bruijn, I. H., Britschgi, C., Bovée, J. V. M. G., Zlobec, I., Sciot, R. and Schöffski, P. (2021) Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research Sarcoma
168. Zadka, L., Chabowski, M., Grybowski, D., Piotrowska, A., and Dziegiel, P. (2021) Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer Cancer Immunology, Immunotherapy
167. Weber, M., Homm, A., Müller, S., Frey, S., Amann, K., Ries, J., Geppert, C., Preidl, R., Möst, T., Kämmerer, P. W., Kesting, M. and Wehrhan, F. (2021) Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo International Journal of Medical Sciences
166. Rao, V., Subramanian, P., Sali, A. P., Menon, S., and Desai, S. B. (2021) Validation of Whole Slide Imaging for primary surgical pathology diagnosis of prostate biopsies Indian Journal of Pathology & Microbiology
2020
165. Nasyrov, R. A., Sidorova, N. A., Melnikova, V. F., and Fedotova, E. P. (2020) Morphological and Immunohistochemical Features of Placental Damage in Cases of Perinatal Death: Institutional Experience with Emphasis on Viral Etiology Ann Clin Lab Sci
164. Jeon, T., Kim, A., and Kim, C. (2020) Automated immunohistochemical assessment ability to evaluate estrogen and progesterone receptor status compared with quantitative reverse transcription-polymerase chain reaction in breast carcinoma patients Journal of Pathology and Translational Medicine
163. Remoué, A., Conan-Charlet, V., Deiana, L., Tyulyandina, A., Marcorelles, P., Schick, U., and Uguen, A. (2020) Breast cancer tumor heterogeneity has only little impact on the estimation of Oncotype DX® recurrence score using Magee equations and Magee Decision Algorithm Human Pathology
162. Grzegrzolka, J., Olbromski, M., Gomulkiewicz, A., Piotrowska, A., Glatzel‑Plucinska, N., Ratajczak, K., Sputa‑Grzegrzolka, P., Rzechonek, A., Werynska, B., Podhorska‑Okolow, M., and Dziegiel, P. (2020) Role of tesmin expression in non‑small cell lung cancer Oncology Letters
161. Ciesielska, U., Piotrowska, A., Kobierzycki, C., Pastuszewski, W., Podhorska-Okolow, M., Dziegiel, P. and Nowinska, K. (2020) Comparison of TMA Technique and Routine Whole Slide Analysis in Evaluation of Proliferative Markers Expression in Laryngeal Squamous Cell Cancer in vivo
160. Gowkielewicz, M., Lipka, A., Majewska, M., Piotrowska, A., Szadurska-Noga, M., Nowakowski, J. J., Wiszpolska, M., Dziegiel, P., Wasniewski, T., Majewski, M. K. and Jozwik, M. (2020) Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue Cells
159. Carpenco, E. (2020) S100 protein in molecular subtypes of breast cancer Moldovan Medical Journal
158. Margan, M. M., Cimpean, A. M., Ceausu, A R., and Raica, M., (2020) Differential Expression of E-Cadherin and P-Cadherin in Breast Cancer Molecular Subtypes Anticancer Research
157. Lehmann, M., Marklund, M., Bolender, A-L., Bidhendi, E. E., Zetterström, P., Andersen, P. M., Brännström, T., Marklund, S. L., Gilthorpe, J. D. and Nordström, U. (2020) Aggregate-selective antibody attenuates seeded aggregation but not spontaneously evolving disease in SOD1 ALS model mice Acta Neuropathologica Communications, September 2020
156. Deman, F., Punie, K., Laenen, A., Neven, P., Oldenburger, E., Smeets, A., Nevelsteen, I., Van Ongeval, C., Baten, A., Faes, T., Christiaens, M., Janssen, H., Weltens, C., Desmedt, C., Wildiers, H. and Floris, G. (2020) Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes Epidemiology, September 2020
155. Egeland, NG., Jonsdottir, K., Lauridsen, KL., Skaland, I., Hjorth, CF., Gudlaugsson, EG., Hamilton-Dutoit, S., Lash, TL., Cronin-Fenton, D., and Janssen, EAM. (2020). Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients. DovePress, July 2020
154. Shipitsin, M., Giladi, E., Small III, C., Nifong, T., Dunyak, J., and Blume-Jensen, P. (2020). Tumor Markers FUS, SMAD4, DERL1, YBX1, PS6, PDSS2, CUL2, and HSPA9 for Analyzing Prostate Tumor Samples. FPO, May 2020
153. Luksza, M., Balachandran, V. P., Levin, A. J., Wolchok, J. D., Merghoub, T., Leach, S. D., Chan, T. A., Greenbaum, B. D., and Laessig, M. (2020) Neoantigens and uses thereof for treating cancer (United States Patent Application 20200232040) Free Patents Online
152. Contat, C., Ancey, P-B., Zangger, N., Sabatino, S., Pascual, J., Escrig, S., Jansen, L., Goepfert, C., Lanz, B. et al (2020) Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth eLife Sciences
151. Somri-Gannam, L., Meisel-Sharon, S., Hantisteanu, S., Groisman, G., Limonad, O., Hallak, M., and Bruchim, I. (2020) IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer Science Direct
150. Tanaka, A., Zhou, Y., Ogawa, M., Shia, J., Klimstra, D. S., Wang, J. Y., Roehrl, M. H. (2020) STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability PLOS One
149. Tian, C., Öhlund, D., Rickelt, S., Lidström, T., Huang, Y., Hao, L., Zhao, R. T., Franklin, O., Bhatia, S. N., Tuveson, D. A., Hynes, R. O. (2020) Cancer-cell derived matrisome proteins promote metastasis in pancreatic ductal adenocarcinoma Cancer Research
148. Pelon F., Bourachot B., Kieffer Y., Magagna I., Mermet-Meillon F., Bonnet I., Costa A., Givel A-M., Attieh Y., Barbazan J., Bonneau C., Fuhrmann L., Descroix S., Vignjevic D., Silberzan P., Parrini M C., Vincent-Salomon A., Mechta-Grigoriou F. (2020) Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms Nature
2019
147. Coltharp, C., PhD, Remeniuk, B. PhD, Wang, C., Schaefer, R., Liu, L., Milton, G., Duckworth, V., McLane, M., Miller, P., and Zheng, Y. (2019). P31 Applying multispectral unmixing and spatial analyses to explore tumor heterogeneity with a pre-optimized 7-color immuno-oncology workflow. Salivary levels and immunohistochemical expression of selected angiogenic factors in benign and malignant parotid gland tumours. Journal for ImmunoTherapy of Cancer, November 2019
146. Schoffski, P., Lee, C-J., Van Cann, T., Wellens, J., Zlobec, I., Bovée, J. V. M. G., Britschgi, C., Sciot, R., Wozniak. A. (2019)Establishment of a tissue microarray (TMA) platform as an efficient tool for soft tissue sarcoma (STS) research available for collaboration Journal of Global Oncology
145. Lasurinen, A,., Gramolelli, S., Hagström, J., Laitinen, A., Kokkola, A., Miki Y., Lehti, K., Yashiro, M., Ojala, P. M., Böckelman, C., Haglund C. (2019) High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1 Wiley Cancer Medicine
144. Vesterinen T., Salmenkivi K., Mustonen H., Kuopio T., Lappi-Blanco E., Paavonen T., Vainio P., Knuuttila A., Carpén O., Haglund C., Arola J. (2019) Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research Virchows Archive
143. Böhm J., Muenzner J. K., Caliskan A., Ndreshkjana B., Erlenbach-Wünsch K., Merkel S., Croner R., Rau T. T., Geppert C. I., Hartmann A., Vial Roehe A., Schneider-Stock R. (2019) Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells Journal of Cancer Research and Clinical Oncology
142. Valcz G., Buzás E.I., Kittel Á.,Krenács T., Visnovitz T., Spisák S., Török Gy., Homolya L., Zsigrai S., Kiszler G., Antalffy G., Pálóczi K., Szállási Z., Szabó V., Sebestyén A., Solymosi N., Kalmár A., Dede K., Lőrincz P., Tulassay Zs., Igaz P., Molnár B. (2019) En bloc release of MVB-like small extracellular vesicle clusters by colorectal carcinoma cells Journal of Extracellular Vesicles
141. Carpenco E., Ceaşu R. A., Cimpean A.M., Gaje P.N., Șaptefraţi L., Fulga V., David V., Raica M. (2019) Mast Cells as an Indicator and Prognostic Marker in Molecular Subtypes of Breast Cancer In Vivo
140. Hötzel K. J., Havnar C. A., Ngu H. V., Rost S., Liu S. D., Rangell L. K., Peale F. V. (2019) Synthetic Antigen Gels as Practical Controls for Standardized and Quantitative Immunohistochemistry Journal of Histochemistry & Cytochemistry
139. Aporowicz M., Czopnik P., Kubicka E., Piotrowska A., Dziegiel P., Bolanowski M. and Domoslawski P. (2019) Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors Anticancer Research
138. Pawelczyk K., Piotrowska A., Ciesielska U., Jablonska K., Glatzel-Plucinska N., Grzegrzolka J., Podhorska-Okolow M., Dziegiel P., and Nowinska K. (2019) Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers International Journal of Molecular Sciences
137. Haller F., Bieg M., Will R., Körner C., Weichenhan D., Bott A., Ishaque N., Lutsik P., Moskalev E.A., Mueller S.K., Bähr M., Woerner A., Kaiser B., Scherl C., Haderlein M., Kleinheinz K., Fietkau R., Iro H., Eils R., Hartmann A., Plass C., Wiemann S., Agaimy A. (2019) Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands Nature Communications volume 10, Article number: 368
136. Kneppers J., Krijgsman O., Melis M., de Jong J., Peeper D. S., Bekers E., van der Poel H.G., Zwart W. Bergman A.M. (2019) Frequent clonal relations between metastases and non-index prostate cancer lesions
2018
135. Acs B., Pelekanou V., Bai Y., Martinez-Morilla S., Toki M., Leung SCY., Nielsen TO., Rimm DL. (2018) Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study.
134. Helin H., Tolonen T., Ylinen O., Tolonen P., Näpänkangas J., Isola J. (2018) Optimized JPEG 2000 Compression for Efficient Storage of Histopathological Whole-Slide Images.
133. Yang L., Jiawei Y., Cao S., Guo L., Sirui L., Luwei Z., Cuixia D., Lu G., Yupei W., Rong Z., Jing S., Hong Z. (2018). Ameliorating mitochondrial dysfunction restores carbon ion-induced cognitive deficits via co-activation of NRF2 and PINK1 signaling pathway
132. Glatzel-Plucinska, N., Piotrowska, A., Grzegrzolka, J., Olbromski, M., Rzechonek, A., Dziegiel, P., and Podhorska-Okolow, M. (2018). SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma. Anticancer Res. 38, 723–736.
131. Hadgu, E., Seifu, D., Tigneh, W., Bokretsion, Y., Bekele, A., Abebe, M., Sollie, T., Merajver, S.D., Karlsson, C., and Karlsson, M.G. (2018). Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. BMC Womens Health 18, 40.
130. Błochowiak, K., Sokalski, J., Golusińska, E., Trzybulska, D., Witmanowski, H., Bodnar, M., and Marszałek, A. (2018). Salivary levels and immunohistochemical expression of selected angiogenic factors in benign and malignant parotid gland tumours. Clin Oral Invest 1–12.
129. Brantley, K.D., Kjærsgaard, A., Cronin-Fenton, D., Yacoub, R., Nielsen, A.S., Lauridsen, K.L., Hamilton-Dutoit, S., and Lash, T.L. (2018). Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence. Cancer Epidemiol Biomarkers Prev.
128. Chauvin, A., Wang, C.-S., Geha, S., Garde-Granger, P., Mathieu, A.-A., Lacasse, V., and Boisvert, F.-M. (2018). The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature. Clinical Proteomics 15, 16.
127. Toth, L., Nagy, B., Mehes, G., Laszlo, E., Molnar, P.P., Poka, R., and Hernadi, Z. (2018). Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites—Correlation of tissue microarray and cytology microarray. Pathology – Research and Practice 214, 978–985.
126. Birkman, E.-M., Mansuri, N., Kurki, S., Ålgars, A., Lintunen, M., Ristamäki, R., Sundström, J., and Carpén, O. (2018). Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics. Virchows Arch. 472, 369–382.
125. Conemans, E.B., Raicu-Ionita, G.M., Pieterman, C.R.C., Dreijerink, K.M.A., Dekkers, O.M., Hermus, A.R., Herder, W.W. de, Drent, M.L., Horst-Schrivers, A.N.A. van der, Havekes, B., et al. (2018). Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors. J Endocrinol Invest 41, 655–661.
124. David, S.N., Egloff, S.A.A., Goyal, R., Clark, P.E., Phillips, S., Gellert, L.L., Hameed, O., and Giannico, G.A. (2018). MAGI2 is an independent predictor of biochemical recurrence in prostate cancer. The Prostate 78, 616–622.
123. Depciuch, J., Stanek-Widera, A., Lange, D., Biskup-Frużyńska, M., Stanek-Tarkowska, J., Czarny, W., and Cebulski, J. (2018). Spectroscopic analysis of normal and neoplastic (WI-FTC) thyroid tissue. Spectrochim Acta A Mol Biomol Spectrosc 204, 18–24.
122. El Ansari, R., Craze, M.L., Miligy, I., Diez-Rodriguez, M., Nolan, C.C., Ellis, I.O., Rakha, E.A., and Green, A.R. (2018). The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours. Breast Cancer Research 20, 21.
121. Guleria, P., Husain, N., Shukla, S., Kumar, S., Parshad, R., and Jain, D. (2018). PD-L1 immuno-expression assay in thymomas: Study of 84 cases and review of literature. Ann Diagn Pathol 34, 135–141.
120. Kobierzycki, C., Grzegrzolka, J., Glatzel-Plucinska, N., Piotrowska, A., Wojnar, A., Smolarz, B., Romanowicz, H., and Dziegiel, P. (2018). Expression of p16 and SATB1 in Invasive Ductal Breast Cancer – A Preliminary Study. In Vivo 32, 731–736.
119. Laedrach, C., Salhia, B., Cihoric, N., Zlobec,I., Tapia, C. (2018). Immunophenotypic profile of tumor buds in breast cancer. Pathol. Res. Pract. [Epub ahead of print]
118. Morin, E., Sjöberg, E., Tjomsland, V., Testini, C., Lindskog, C., Franklin, O., Sund, M., Öhlund, D., Kiflemariam, S., Sjöblom, T., et al. (2018) VEGF receptor-2/neuropilin1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival. The Journal of Pathology.
117. Neyaz, A., Husain, N., Gupta, S., Kumari, S., Arora, A., Awasthi, N.P., Malhotra, K.P., and Misra, S. (2018). Investigation of targetable predictive and prognostic markers in gallbladder carcinoma. J Gastrointest Oncol 9, 111–125.
116. Neyaz, A., Husain, N., Kumari, S., Gupta, S., Shukla, S., Arshad, S., Anand, N., and Chaturvedi, A. (2018) Clinical relevance of PD-L1 expression in gallbladder cancer: a potential target for therapy. Histopathology.
115. Ooft, M.L., Ipenburg, J. van, Loo, R.J.M. van de, Jong, R. de, Moelans, C.B., Bree, R. de, Herdt, M.J. de, Koljenović, S., Jong, R.B. de, Hardillo, J., et al. (2018) Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma. Head & Neck.
114. Pokataev, I., Kudaibergenova, A., Artemyeva, A., Popova, A., Rumyantsev, A., Podluzhny, D., Kudashkin, N., Fedyanin, M., Tryakin, A., and Tjulandin, S. (2018). Intratumoral Heterogeneity of SMAD4 Immunohistochemical Expression and Its Role in Prediction of Recurrence Pattern in Patients with Resectable Pancreatic Cancer. J Gastrointest Canc 1–7.
113. Suster, D., Pihan, G., Mackinnon, A.C., and Suster, S. (2018). Expression of PD-L1/PD-1 in lymphoepithelioma-like carcinoma of the thymus. Modern Pathology 1.
112. Vesterinen, T., Mononen, S., Salmenkivi, K., Mustonen, H., Ilonen, I., Knuuttila, A., Haglund, C., and Arola, J. (2018). Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor. Acta Oncologica 57, 1109–1116.
111. Visser , N.C.M., Wurff, A.A.M. van der, Pijnenborg, J.M.A., Massuger, L.F.A.G., Bulten, J., and Nagtegaal, I.D. (2018). Tissue microarray is suitable for scientific biomarkers studies in endometrial cancer. Virchows Arch. 1–7.
110. Wartenberg, M., Cibin, S., Zlobec, I., Vassella, E., Eppenberger-Castori, S., Terracciano, L., Eichmann, M.D., Worni, M., Gloor, B., Perren, A., et al. (2018). Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance.Clin Cancer Res.
109. Zadka, Ł., Kulus, M.J., Kurnol, K., Piotrowska, A., Glatzel-Plucińska, N., Jurek, T., Czuba, M., Nowak, A., Chabowski, M., Janczak, D., et al. (2018). The expression of IL10RA in colorectal cancer and its correlation with the proliferation index and the clinical stage of the disease. Cytokine 110, 116–125.
108. Graule, J., Uth, K., Fischer, E., Centeno, I., Galván, J.A., Eichmann, M., Rau, T.T., Langer, R., Dawson, H., Nitsche, U., et al. (2018). CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway. Clin. Epigenetics 10, 120.
2017
107. Tanggang, B., Guobei Y., Xin S., Lin X., Yu Z., Jianglin L., Xiaoxiao H., Zhen L., Jun H., Yibin Z., Hui Z., Yang S., Peifu F., Dong W., Bin H., Jing L., Weihong T., Mao Y. (2017). Deubiquitylation and stabilization of p21 by USP11 is critical for cell-cycle progression and DNA damage responses
106. Ying L., Xiaoxiao H., Linlin W., Xiangjun L., Tao B., Weihong T., Dihua S. (2017.) Quinacridone derivative as a new photosensitizer: Photodynamic effects in cells and in vivo
105. Bengtsson E, Danielsen H, Treanor D, Gurcan MN, MacAulay C, Molnár B. (2017): Computer-aided diagnostics in digital pathology. CYTOMETRY A Jun;91(6):551-554.
104. Paulik R, Micsik T, Kiszler G, Kaszál P, Székely J, Paulik N, Várhalmi E, Prémusz V, Krenács T, Molnár B, (2017): An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology.
CYTOMETRY PART A 91:(6) pp. 596-608.
103. Nolte, S., Zlobec, I., Lugli, A., Hohenberger, W., Croner, R., Merkel, S., Hartmann, A., Geppert, C.I., and Rau, T.T. (2017). Construction and analysis of tissue microarrays in the era of digital pathology: a pilot study targeting CDX1 and CDX2 in a colon cancer cohort of 612 patients. J. Pathol. Clin. Res. 3, 58–70.
102. Giovannetti, E., Zucali, P.A., Assaraf, Y.G., Funel, N., Gemelli, M., Stark, M., Thunnissen, E., Hou, Z., Muller, I.B., Struijs, E.A., et al. (2017). Role of proton-coupled folate transporter in pemetrexed-resistance of mesothelioma: clinical evidence and new pharmacological tools. Ann. Oncol.
101. Rau, K.-M., Su, Y.-L., Li, S.-H., Hsieh, M.-C., Wu, S.-C., Chou, F.-F., Chiu, T.-J., Chen, Y.-H., and Liu, C.-T. (2017). High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy. Mol. Med. Rep. 16, 7185–7190.
100. Lin, F. (2017). Immunohistochemistry Quality Management Program Using Cultured Cell Lines for Tissue Microarray (TMA) Blocks.
99. Fu, X., Lennerz, J. K.,, Onozato, M., Iafrate, A., Yagi, Y. (2017). Evaluation of a confocal WSI scanner for FISH slide imaging and image analysis. Diagnostic Pathology 2017, 3: 249.
98. Loibner, M., Oberauner-Wappis, L., Viertler, C., Groelz, D., and Zatloukal, K. (2017). Protocol for HER2 FISH Using a Non-cross-linking, Formalin-free Tissue Fixative to Combine Advantages of Cryo-preservation and Formalin Fixation. J Vis Exp. 2017; (130): 55885.
97. Scheel, A.H., Baenfer, G., Baretton, G., Dietel, M., Diezko, R., Henkel, T., Heukamp, L.C., Jasani, B., Jöhrens, K., Kirchner, T., et al. (2017). Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer. Histopathology 72, 449–459.
2016
96. Leenen, L. P. H., & Blokhuis, T. J. (2016). Neutrophils contribute to fracture healing by synthesizing fibronectin+ extracellular matrix rapidly after injury. Clinical Immunology, 164, 78–84.
95. Valcz, G., Galamb, O., Krenács, T., Spisák, S., Kalmár, A., Patai V. Á., Wichmann, B., Dede, K., Tulassay, Zs. and Molnár, B. (2016). Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass. Modern Pathology, 2016 Aug.
94. Koole, K., Clausen, M.J.A.M., Es, R.J.J., Kempen, P.M.W., Melchers, L.J., Koole, R., Langendijk, J.A., Diest, P.J., Roodenburg, J.L.N., Schuuring, E., et al. (2016). FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. Mol. Diagn. Ther. 1–12.
93. Green, W.J., Ball, G., Hulman, G., Johnson, C., Van Schalwyk, G., Ratan, H.L., Soria, D., Garibaldi, J.M., Parkinson, R., Hulman, J., et al. (2016). KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach. Br. J. Cancer.
92. Koole, K., Peeters, T., van Hengel, O.R.J., Brinkhuis, A., van Es, R.J.J., and Willems, S.M. (2016). RET protein is overexpressed in oral squamous cell carcinoma. Histopathology doi: 10.1111/his.13023.
91. Butz, H., Németh, K., Czenke, D., Likó, I., Czirják, S., Zivkovic, V., Baghy, K., Korbonits, M., Kovalszky, I., Igaz, P., et al. (2016). Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
Pathol. Oncol. Res. 1–9.
90. Adriaens, C., Standaert, L., Barra, J., Latil, M., Verfaillie, A., Kalev, P., Boeckx, B., Wijnhoven, P.W.G., Radaelli, E., Vermi, W., et al. (2016). p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat. Med. 22, 861–868.
2015
89. Goos, J.A.C.M., de Cuba, E.M.V., Coupé, V.M.H., Diosdado, B., Delis-Van Diemen, P.M., Karga, C., Beliën, J.A.M., Menke-Van der Houven van Oordt, C.W., Geldof, A.A., Meijer, G.A., et al. (2015).
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis:
Ann. Surg. 1.
88. Aleskandarany, M., Caracappa, D., Nolan, C., C., Macmillan, D., R., Ellis, I., O., Rakha. E., A., and Green, A., E. (2015).
DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
Breast Cancer Research and Treatment. 10.1007/s10549-015-3306-6
87. Dale, Oliver T., Tamara Aleksic, Ketan A. Shah, Cheng Han, Hisham Mehanna, Davy C. M. Rapozo, Jon D. H. Shear. (2015).
IGF-1R Expression Is Associated with HPV Negative Status and Adverse Survival in Head and Neck Squamous Cell Cancer.
Carcinogenesis. bgv053. doi:10.1093/carcin/bgv053.
86. Lacombe, A., Carafa, V., Schneider, S., Sticker-Jantscheff, M., Tornillo, L., and Eppenberger-Castori, S. (2015).
Re-Punching Tissue Microarrays Is Possible: Why Can This Be Useful and How to Do It.
Microarrays 4, 245–254.
85. Vassella, E., Galván, J.A., and Zlobec, I. (2015).
Tissue Microarray Technology for Molecular Applications: Investigation of Cross-Contamination between Tissue Samples Obtained from the Same Punching Device.
Microarrays 4, 188–195.
84. Lindskog, C., Linné, J., Fagerberg, L., Hallström, B.M., Sundberg, C.J., Lindholm, M., Huss, M., Kampf, C., Choi, H., Liem, D.A., et al. (2015).
The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling.
BMC Genomics 16, 475.
2014
83. Mitsuyoshi Honjo, MD, Fuminori Moriyasu, MD, PhD, Katsutoshi Sugimoto, MD, PhD, Hisashi Oshiro, MD, PhD, Kentaro Sakamaki, PhD, Kazuhiko Kasuya, MD, PhD, Takeshi Nagai, MD, Akihiko Tsuchida, MD, PhD and Yasuharu Imai, MD, PhD
Relationship Between the Liver Tissue Shear Modulus and Histopathologic Findings Analyzed by Intraoperative Shear Wave Elastography and Digital Microscopically Assisted Morphometry in Patients With Hepatocellular Carcinoma
JUM January 2014 33:61-71
82. Chang, H., Peluso, D., Hussain, S., Shipitsin, M., and Blume-Jensen, P. (2014).
Optimizing tissue microarray construction procedure to improve quality of sections.
J. Histotechnol. 37, 95–100.
81. Hajnalka Rajnai, Ivett Teleki, Gergo Kiszner, Nora Meggyesházi, Peter Balla, Tamas Vancsik, Györgyi Muzes,Judit Csomor, András Matolcsy, and Tibor Krenács (2014).
Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas.
J. of Immunology Res. In Press
80. Zlobec, I., Suter, G., Perren, A., and Lugli, A. (2014).
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies.
J. Vis. Exp. 91.
2013
79. Stelkovics E, Kiszner G, Meggyeshazi N, Korom I, Varga E, Nemeth I, Molnar J, Marczinovits I, Krenacs T. (2013): Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin
Histol Histopathol (2013) 28: 941-954
78. Van Oosterwijk JG, Meijer D, van Ruler MA, van den Akker BE, Oosting J, Krenács T, Picci P, Flanagan AM, Liegl-Atzwanger B, Leithner A, Athanasou N, Daugaard S, Hogendoorn PC, Bovée JV. (2013): Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential Targets
Am J Pathol. 2013 Apr;182(4):1347-56. (doi: 10.1016/j.ajpath.2012.12.036.)
77. Verbeke SL, Bertoni F, Bacchini P, Oosting J, Sciot R, Krenács T, Bovée JV. (2013). Active TGF-b signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart
Modern Pathology 2013 Apr 19. (doi: 10.1038/modpathol.2013.56.)
76. Chaisuparat, R., Yodsanga, S., Montaner, S., and Jham, B.C. (2013). Activation of the Akt/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas.
Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 116, 336–342.
75. Giorgio, E.D., Clocchiatti, A., Piccinin, S., Sgorbissa, A., Viviani, G., Peruzzo, P., Romeo, S., Rossi, S., Tos, A.P.D., Maestro, R., et al. (2013). MEF2 Is a Converging Hub for Histone Deacetylase 4 and Phosphatidylinositol 3-Kinase/Akt-Induced Transformation.
Mol. Cell. Biol. 33, 4473–4491.
74. Goos, J. a. C.M., Coupe, V.M.H., Diosdado, B., Delis-Van Diemen, P.M., Karga, C., Beliën, J. a. M., Carvalho, B., van den Tol, M.P., Verheul, H.M.W., Geldof, A.A., et al. (2013). Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.
Br. J. Cancer 109, 2445–2452.
73. De Graaff, M.A., Cleton-Jansen, A.-M., Szuhai, K., and Bovée, J.V.M.G. (2013). Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
Hum. Pathol. 44, 1597–1604.
72. Ohtomo, R., Mori, T., Shibata, S., Tsuta, K., Maeshima, A.M., Akazawa, C., Watabe, Y., Honda, K., Yamada, T., Yoshimoto, S., et al. (2013). SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
Mod. Pathol. 26, 1041–1050.
71. Zlobec, I., Koelzer, V.H., Dawson, H., Perren, A., and Lugli, A. (2013). Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types.
J. Transl. Med. 11, 104.
70. Laurent, C., Guérin, M., Frenois, F-X.,Thuries, V., Jalabert, L., Brousset, P., Valmary-Degano, S.. (2013). Whole-slide imaging is a robust alternative to traditional fluorescent microscopy for fluorescence in situ hybridization imaging using break-apart DNA probes.
Human Pathology Volume 44, Issue 8, Pages 1544–1555.
69. Kiszler, G., Krecsák, L., Csizmadia, A., Micsik, T., Szabó, D., Jónás, V., Prémusz, V., Krenács, T., Molnár, B. (2013). Semi-automatic FISH quantification on digital slides.
Diagn Pathol. 2013; 8(Suppl 1): S21..
2012
68. Varga VS, Molnár B, Virág T. (2012): Automated high throughput whole slide imaging using area sensors, flash light illumination and solid state light engine.
Stud Health Technol Inform. 2012;179:187-202.)
67. Fónyad L, Krenács T, Nagy P, Zalatnai A, Csomor J, Sápi Z, Pápay J, Schönléber J, Diczházi Cs, Molnár B. (2012): Validation of diagnostic accuracy using digital slides in routine histopathology.
Diagnostic Pathology 2012, 7:35 (doi:10.1186/1746-1596-7-35)
66.. Krenacs T, Kiszner G, Stelkovics E, Balla P, Teleki I, Nemeth I, Varga E, Korom I, Barbai T, Plotar V, Timar J, Raso E. (2012): Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis.
Histochem Cell Biol. 2012 Oct;138(4):653-67. (doi: 10.1007/s00418-012-0981-9.)
65. Rajnai H, Bödör Cs, Balogh Zs, Gagyi É, Csomor J, Krenács T, Tóth E, Matolcsy A. (2012): Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma.
Histophatology (doi: 10.1111/j.1365-2559.2012.04187.x)
64. Rossing HH, Talman MLM, Lænkholm AV, Wielenga VT. (2012): Implementation of TMA and digitalization in routine diagnostics of breast pathology.
Acta Pathologica Microbiologica et Immunologica Scandinavica 2012, 120:4 (DOI: 10.1111/j.1600-0463.2011.02871.x)
63. Bignotti, E., Zanotti, L., Calza, S., Falchetti, M., Lonardi, S., Ravaggi, A., Romani, C., Todeschini, P., Bandiera, E., Tassi, R.A., et al. (2012). Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.
BMC Clin. Pathol. 12, 22.
62. Laurinavicius, A., Laurinaviciene, A., Ostapenko, V., Dasevicius, D., Jarmalaite, S., and Lazutka, J. (2012). Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.
Diagn. Pathol. 7, 27.
2011
61. Baka Z, Barta P, Losonczy G, Krenács T, Pápay J, Szarka E, Sármay G, Babos F, Magyar A, Géher P, Buzás EI, Nagy G. (2011): Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.
Int Immunol. 2011 Jun;23(6):405-14. (doi: 10.1093/intimm/dxr026)
60. Balla P, Moskovszky L, Sapi Z, Forsyth R, Knowles H, Athanasou NA, Szendroi M, Kopper L, Rajnai H, Pinter F, Petak I, Benassi MS, Picci P, Conti A, Krenacs T. (2011): Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
Histopathology. 2011 Sep;59(3):376-89. (doi: 10.1111/j.1365-2559.2011.03948.x.)
59. Egervári G, Márk A, Hajdu M, Barna G, Sápi Z, Krenács T, Kopper L, Sebestyén A. (2011): Mitotic lymphoma cells are characterized by high expression of phosphorylated ribosomal S6 protein.
Histochem Cell Biol. 2011 Apr;135(4):409-17. doi: 10.1007/s00418-011-0803-5
58. Gong P, Roseman J, Fernandez CG, Vetrivel KS, Bindokas VP, Zitzow LA, Kar S, Parent AT, Thinakaran G. (2011): Transgenic neuronal overexpression reveals that stringently regulated p23 expression is critical for coordinated movement in mice.
Molecular Neurodegeneration 2011, 6:87 (doi:10.1186/1750-1326-6-87)
57. Huijts PEA, Dongen v. M, Goeij de MCM, Moolenbroek v. AJ, Blanken F, Vreeswijk MPG, Kruijf de EM, Mesker WE, Zwet v. EW, Tollenaar RAEM, Smit VTHBM, Asperen v. CJ, Devilee P. (2011): Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
Breast Cancer Research 2011, 13:R72 (doi:10.1186/bcr2917)
56. Huss S, Fronhoffs F, Büttner R, Heukamp LC. (2011): Web-based database for the management of tissue specimens in a transregional histological research facility.
Diagnostic Pathology 2011, 6:17 (doi:10.1186/1746-1596-6-17)
55. Krecsák L, Micsik T, Kiszler G, Krenács T, Szabó D, Jónás V, Császár G, Czuni L, Gurzó P, Ficsor L, Molnár B. (2011): Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer.
Diagnostic Pathology 2011, 6:6 (doi: 10.1186/1746-1596-6-6)
54. Kayser K, Borkenfeld S, Goldmann T, Kayser G. (2011): Virtual slides in peer reviewed, open access medical publication.
Diagnostic Pathology 2011, 6:124 (doi: 10.1186/1746-1596-6-124)
53. Lee RE, McClintock DS, Laver NM, Yagi Y. (2011): Evaluation and optimization for liquid-based preparation cytology in whole slide imaging.
Journal of Pathology Informatics 2011, 2:46 (doi: 10.4103/2153-3539.86285)
52. Maggiani F, Forsyth R, Hogendoorn PC, Krenacs T, Athanasou NA. (2011): The immunophenotype of osteoclasts and macrophage polykaryons.
J Clin Pathol. 2011 Aug;64(8):701-5. (doi: 10.1136/jcp.2011.090852.)
51. Meijer D, Gelderblom H, Karperien M, Cleton-Jansen AM, Hogendoorn PCW, Bovée JVMG. (2011): Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo.
Clinical Sarcoma Research 2011, 1:5 (doi:10.1186/2045-3329-1-5)
50. Pansuriya TC, Oosting J, Krenács T, Taminiau AHM, Verdegaal SHM, Sangiorgi L, Sciot R, Hogendoorn PCW, Szuhai K, Bovée JVMG. (2011): Genome-wide analysis of Ollier disease: Is it all in the genes?
Orphanet Journal of Rare Diseases 2011, 6:2 (doi:10.1186/1750-1172-6-2)
49. Szasz AM, Nemeth Zs, Gyorffy B, Micsinai M, Krenacs T, Baranyai Zs, Harsanyi L, Kiss A, Schaff Zs, Tokes A, Kulka J. (2011): Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer.
Cancer Science V102, (12):2248-2254 (doi: 10.1111/j.1349-7006.2011.02085.x)
48. Szasz AM, Tokes AM, Micsinai M, Krenacs T, Jakab C, Lukacs L, Nemeth Z, Baranyai Z, Dede K, Madaras L, Kulka J. (2011): Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis.
Clin Exp Metastasis. 2011 Jan;28(1):55-63. (doi: 10.1007/s10585-010-9357-5.)
47. Szymas J, Lundin M. (2011): Five years of experience teaching pathology to dental students using the WebMicroscope.
Diagnostic Pathology 2011, 6(Suppl 1):S13 (doi: 10.1186/1746-1596-6-S1-S13)
46. Tamás L, Szentkúti G, Erős M, Dános K, Brauswetter D, Szende B, Zsákovics I, Krenács T. (2011): Differential Biomarker Expression in Head and Neck Cancer Correlates with Anatomical Localization.
Pathology & Oncology Research V17 (3):721-727 (doi: 10.1007/s12253-011-9376-9)
44. Than NG, Romero R, Meiri H, Erez O, Xu Y, et al. (2011): PP13, Maternal ABO Blood Groups and the Risk Assessment of Pregnancy Complications.
PLoS ONE 6(7):e21564. (doi:10.1371/journal.pone.0021564)
43. Valcz G, Krenács T, Sipos F, Patai ÁV, Wichmann B, Leiszter K,Tóth K, Balogh Zs, Csizmadia A, Hagymási K, Masszi T, Molnár B, Tulassay Zs. (2011): Lymphoid aggregates may contribute to the migration and epithelial commitment of bone marrow-derived cells in colonic mucosa.
Journal of Clinical Pathology 2011, 64:771-775 (doi:10.1136/jclinpath-2011-200022)
2010
42. Alberghini M, Kliskey K, Krenacs T, Picci P, Kindblom L, Forsyth R, Athanasou NA. (2010): Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone.
Virchows Arch. 2010 Jan;456(1):97-103. (doi: 10.1007/s00428-009-0863-2)
41. Fónyad L, Gerely L, Cserneky M, Molnár B, Matolcsy A. (2010): Shifting gears higher – digital slides in graduate education – 4 years experience at Semmelweis University.
Diagnostic Pathology 2010, 5:73 (doi: 10.1186/1746-1596-5-73)
40. Krenacs T, Ficsor L, Varga SV, Angeli V, Molnar B. (2010): Digital microscopy for boosting database integration and analysis in TMA studies.
Methods Mol Biol. 2010;664:163-75. (doi: 10.1007/978-1-60761-806-5_16.)
39. Krenacs T, Zsakovics I, Micsik T, Fonyad L, Varga V.S, Ficsor L, Kiszler G and Molnar B. (2010): Digital microscopy – the upcoming revolution in histopathology teaching, diagnostics, research and quality assurance
MICROSCOPY Book Series – Number 4 (p.965 – 977)
38. Francz, M., Egervari, K., Kardos, L., Toth, J., Nemes, Z., Szanto, J., and Szollosi, Z. (2010). Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study.
J. Clin. Pathol. 63, 341–346.
2009
37. Badhwara A, Chakravartya MM, Zehntnera SP, Hamelb E, Bedella BJ (2009): Automated quantification of vascular and parenchymal beta-amyloid burdens in a transgenic mouse model of Alzheimer’s disease.
Journal of the Neurological Sciences 283: 253. (doi:10.1016/j.jns.2009.02.058)
36. Rocha RM, Miller K, Soares F, Schenka N, Vassallo J, Gobbi H (2009): Biotin-free systems provide stronger immunohistochemical signal in oestrogen receptor evaluation of breast cancer.
Journal of Clinical Pathology, 62: 699–704. (doi:10.1136/jcp.2009.065326)
35. Krenacs T, Zsakovics I, Diczhazi C, Ficsor L, Varga VS, Molnar B. (2009): The potential of digital microscopy in breast pathology.
Pathol Oncol Res. 2009 Mar;15(1):55-8. (doi: 10.1007/s12253-008-9087-z.)
34. Varga VS, Ficsor L, Kamarás V, Jónás V, Virág T, Tulassay Zs, Molnár B. (2009): Automated multichannel fluorescent whole slide imaging and its application for cytometry.
Cytometry Part A 75A (12):1020-1030 (doi: 10.1002/cyto.a.20791)
2008
33. ConwayC, Dobson L, O’Grady A, Kay E, Costello S, O’Shea D. (2008): Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs.
Histochemistry and Cell Biology 130:447–463. (DOI 10.1007/s00418-008-0480-1)
32. DeAgustín D, Sanmartín J, Varela-Centelles P, Vidal S, Seoane J. (2008): Technological Bases for Teledermatopathology: State of the Art.
Seminars in Cutaneous Medicine and Surgery 27: 25–31. (doi:10.1016/j.sder.2008.01.007)
31. Ficsor L, Varga VS, Tagscherer A, Tulassay Z, Molnar B. (2008): Automated classification of inflammation in colon histological sections.
Cytometry Part A 73A(3):230–237. (DOI: 10.1002/cyto.a.20527)
30. Galamb O, Sipos F, Solymosi N, Spisák S, Krenács T, Tóth K, Tulassay Z, Molnár B. (2008): Diagnostic mRNA expression patterns of inflamed, benign and malignant colorectal biopsy specimen and their correlation with peripheral blood results.
Cancer Epidemiology Biomarkers & Prevention 17(10): 2835–2845. (doi:10.1158/1055-9965.EPI-08-0231)
29. Geurts JJG, Barkhof F. (2008): Grey matter pathology in multiple sclerosis.
The Lancet Neurology 7: 841–851.
28. Kalló I, Jekkel Cs, Hrabovszky E, Jurányi Zs, Vida B, Járási A, Wilheim T, Harsing LG Jr., Liposits Zs. (2008): Immunohistochemical and in situ hybridization studies on glycine transporter 1 after transient ischemia in the rat forebrain.
Neurochemistry International 52: 799–808. (doi:10.1016/j.neuint.2007.09.011)
27. Nedjic J, Aichinger M, Emmerich J, Mizushima N, Klein L. (2008): Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance.
Nature 455: 396–400. (doi:10.1038/nature07208)
26. Seeley EH, Stacey R. Oppenheimer SR, Mi D, Chaurand P, Caprioli RM. (2008): Enhancement of Protein Sensitivity for MALDI Imaging Mass Spectrometry After Chemical Treatment of Tissue Sections.
Journal of the American Society for Mass Spectrometry 19: 1069–1077. (doi:10.1016/j.jasms.2008.03.016)
25. Stelkovics E, Korom I, Marczinovits I, Molnar J, Rasky K, Raso E, Ficsor L, Molnar B, Kopper L, Krenacs T. (2008): Collagen XVII/BP180 Protein Expression in Squamous Cell Carcinoma of the Skin Detected With Novel Monoclonal Antibodies in Archived Tissues Using Tissue Microarrays and Digital Microscopy
Appl Immunohistochem Mol Morphol. 2008 Oct;16(5):433-41. (doi: 10.1097/PAI.0b013e318162f8aa)
24. Than NG, Abdul Rahman O, Magenheim R, Nagy B, Fule T, Hargitai B, Sammar M, Hupuczi P, Tarca AL, Szabo G, Kovalszky I, Meiri H, Sziller I, Rigo J Jr, Romero R, Papp Z. (2008): Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome.
Virchows Archiv 453:387–400. (DOI 10.1007/s00428-008-0658-x)
23. Yagi Y, Gilbertson JR. (2008): A relationship between slide quality and image quality in whole slide imaging (WSI).
Diagnostic Pathology 3(Suppl 1): S12. (doi:10.1186/1746-1596-3-S1-S12)
22. Wittmann G, Deli L, Kalló I, Hrabovszky E, Watanabe M, Liposits ZS, Fekete Cs. (2007): Distribution of Type 1 Cannabinoid Receptor (CB1)-Immunoreactive Axons in the Mouse Hypothalamus.
The Journal of Comparative Neurology 503: 270–279. (DOI 10.1002/cne.21383)
2007
21. Chakravarty MM, Bedell BJ, Zehntner SP, Hemmings K, Hamel E, Evans AC, Collins DL. (2007): P-105. Three dimensional reconstruction of histological sections and correlations with MRI from transgenic models of Alzheimer’s disease.
Alzheimer’s and Dementia 3(3 supplement): S132.
20. Cserni G, Kálmán E, Kulka J, Orosz Z, Udvarhelyi N, Krenács T. (2007): Quality control of HER2 immunohistochemitry – Results from a Hungarian study.
Hungarian Oncology 51:23–29, 2007
19. Faverly, D. (2007): PP1-23 Teleconsultation of breast pathology data: the Belgian-Luxemburg trial.
Virchows Archiv 451(2): 201.
18. Gombás P, Illyés Gy. (2007): OP2-4 Is digital slide microscopy limited to specified morphological applications?
Virchows Archiv (Free Papers (Oral Presentations) 451(2 Suppl.1): 117. (10.1007/s00428-007-0489-1)
17. Hentschel F, Rudolph B, Zhang Z, Schlüns K, Saeger K, Stehr A, Hufnagl P, Schrader T. (2007): 175. Virtual Microscopy in Nephrology – an evaluation study for diagostic accuracy and image quality.
(Posters: Urologic Pathology (2)). Pathology – Research and Practice 203: 316. (doi:10.1016/j.prp.2007.03.004)
16. Krenacs T, Stelkovics E, Raso E, Korom I, Marczinovits I, Kopper L, Timar J. (2007): OP18-2 Over-expression of the hemidesmosomal adhesion protein collagen XVII in malignant melanoma.
Virchows Archiv (Free Papers (Oral Presentations) 451(2 Suppl.1): 159. (10.1007/s00428-007-0489-1)
15. Mager A-K, Liese M, Saeger K, Schlüns K, Hufnagl P, Dietel M, Schlake W, Schrader T. (2007): 155. Virtual Microscopy & T.Konsult Pathologie – The Telepathology Consultation Service of the Professional Association of German Pathologists for the screening program of breast carcinoma.
(Posters: Breast Pathology (2)). Pathology – Research and Practice 203: 308. (doi:10.1016/j.prp.2007.03.004)
14. Moskovszky L, Szendroi M, Sapi Z, Kopper L, Angeli V, Molnar B, Krenacs T. (2007): OP14-9 EGFR signaling in giant cell tumor of bone (GCTB): An immunomorphological tissue microarray (TMA) study using digital slides and database management.
Virchows Archiv (Free Papers (Oral Presentations) 451(2 Suppl.1): 152. (10.1007/s00428-007-0489-1)
13. Papay J, Krenacs T, Moldvay J, Stelkovics E, Furak J, Molnar B, Kopper L. (2007): Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach.
Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):19-30.
12. Persohn E, Seewald W, Bauer J, Schreiber J. (2007): Cell proliferation measurement in cecum and colon of rats using scanned images and fully automated image analysis: Validation of method.
Experimental and Toxicologic Pathology 58: 411–418. (doi:10.1016/j.etp.2007.01.005)
2006
11. Bourde-Vacher K, Poignant S (2006): Analyses d’images.
ITBM-RBM News 27(1): 60–66.
10. Ficsór L, Molnár B, Tulassay Zs. (2006): Experiences in automatic classification of colon and gastric digital slides.
(Poster Abstracts of Third European Congress of Toxicologic Pathology; held in Copenhagen, 29 September–1 October 2005). Experimental and Toxicologic Pathology 57: 395–396. (doi:10.1016/j.etp.2006.04.002)
9. Ficsor L, Varga V, Berczi L, Miheller P, Tagscherer A, Wu MLC, Tulassay Z, Molnar B. (2006): Automated virtual microscopy of gastric biopses.
Cytometry Part B: Clinical Cytometry 70(6): 423–431. (DOI 10.1002/cyto.b)
8. Horváth I, Krajcsovicz Z, Selényi Gy. (2006): Working experience with digital slide and virtual microscopy-based routine toxicopathology evaluation.
(Poster Abstracts of Third European Congress of Toxicologic Pathology; held in Copenhagen, 29 September–1 October 2005). Experimental and Toxicologic Pathology 57: 395. (doi:10.1016/j.etp.2006.04.002)
7. Rojo MG, García GB, Mateos CP, García JG, Vicente MC. (2006): Critical Comparison of 31 Commercially Available Digital Slide Systems in Pathology.
International Journal of Surgical Pathology 14: 285–305. (DOI: 10.1177/1066896906292274)
6. Schrader T, Niepage S, Leuthold T, Saeger K, Schluns K, Hufnagl P, Kayser K, Dietel M. (2006): The diagnostic path, a useful visualisation tool in virtual microscopy.
Diagnostic Pathology 1: 40. (doi:10.1186/1746-1596-1-40)
5. Varga VS, Kamarás V, Csendes G, Virág T, Sipos F, Tulassay Zs, Molnár B. (2006): The advances in scanning fluorescent microscopy (automated slide handling, metal-halide illumination, software features) means significant advantage for routine applications.
(Poster Abstracts of Third European Congress of Toxicologic Pathology; held in Copenhagen, 29 September–1 October 2005). Experimental and Toxicologic Pathology 57: 395. (doi:10.1016/j.etp.2006.04.002)
2005
4. Rojo MG, García GB, Mateos CP, García JG. (2005): Preparaciones digitales en los servicios de Anatomía Patológica (II). Análisis de soluciones existentes.
Revista Española de Patología 38(4): 207–220.
3. Wu ML, Varga VS, Kamaras V, Ficsor L, Tagscherer A, Tulassay Z, Molnar B. (2005): Three-Dimensional Virtual Microscopy of Colorectal Biopsies.
Archives of Pathology & Laboratory Medicine 129: 507-510.
2004
2. Molnar B, Varga VS, Csendes G, Virag T, Tulassay Zs. (2004): 98435. Advances in scanning fluorescent microscopy, (automated slide handling, metal-halide illumination, software features) means significant benefit for routine tissue cytometry.
(ISAC Congress XXII: Oral Presentation Abstracts) Cytometry Part A 59A(1): 40. (doi 10.1002/cyto.a.20044.abs)
1. Varga VS, Bocsi J, Sipos F, Csendes G, Tulassay Zs, Molnár B. (2004): Scanning fluorescent microscopy is an alternative for quantitative fluorescent cell analysis.
Cytometry Part A 60A (1):53-62 (doi: 10.1002/cyto.a.20027)
